Revenue

StickIt Technologies bets on a complex share consolidation and capital raise to survive, but are the terms a red flag for its investors and future?

CDT Equity partners with a top advisory firm to license its drug-enhancing tech, tackling the patent cliff while managing a novel Bitcoin treasury strategy.

Marketing CEO J Franco earns ABWA's top honor, highlighting her entrepreneurial journey and the growing influence of women in the digital economy.

Fintech pioneer Currenc Group divests its payments hub Tranglo in a $400M deal, fueling a bold transformation into AI, Web3, and digital assets.

With a blockbuster 2025 in the books, Boston Scientific's leadership faces intense scrutiny at upcoming investor events to prove its growth is sustainable.

Nexxen doubles down on shareholder returns with a new $40M buyback, signaling deep confidence amid market volatility and a strategic push into CTV.

Cinemark expands its hit 'Bring Your Own Bucket' event with a Lowe's partnership, offering massive popcorn fills for just $5. Here's the inside scoop.

The cruise retailer resumes dividends after a multi-year pause and buys back shares from its founding family, signaling deep confidence in its future.

Genelux appoints Dr. Jason Litten as CMO, a strategic move to steer its promising oncolytic virus, Olvi-Vec, through crucial late-stage cancer trials.

Hoth Therapeutics files patents for a therapy to mitigate severe skin reactions from cancer treatments, a strategic move that could transform patient care.

HVAC/R giant Watsco extends its 52-year dividend streak, signaling robust financial health and a strategy built on market consolidation and AI.

BridgeBio Pharma hosts a key investor webinar on its oral drug infigratinib for achondroplasia, setting the stage for crucial trial results in Q1 2026.

With its acquisition of Lantheus' SPECT business, SHINE Technologies is creating a vertically integrated powerhouse to end isotope shortages.

As robotaxis and self-driving trucks go commercial, a new group from Seeing Machines aims to solve the critical human trust and safety challenge.

Tire giant Michelin buys advanced materials firm Tex-Tech to fuel its diversification, as a new defense-focused composite entity, FMI, is spun off.

Fresh off a major drug approval, Insmed's upcoming J.P. Morgan talk is under scrutiny as investors eye pipeline updates and acquisition potential.

The acquisition of seven Kloeckner service centers marks a major strategic push, expanding Russel Metals' U.S. footprint and value-added capabilities.

A price increase on critical specialty chemicals by Trecora reveals mounting cost pressures that could ripple through automotive, construction, and water treatment.

SmartCentres extends CEO talks, but the end of its founder's special voting rights signals a new era of governance and uncertainty for the REIT's future.

Ironwood Pharma forecasts a massive profit jump by lowering its top drug's price, a bold move as it advances its rare disease pipeline for future growth.